M. Shindo et al., THE CLINICAL-SIGNIFICANCE OF CHANGES IN GENETIC-HETEROGENEITY OF THE HYPERVARIABLE REGION-1 IN CHRONIC HEPATITIS-C WITH INTERFERON THERAPY, Hepatology, 24(5), 1996, pp. 1018-1023
We examined changes in the hypervariable region 1 of the hepatitis C v
irus (HCV) RNA that occurred with interferon therapy in 33 patients wi
th chronic hepatitis C to assess the clinical significance of this reg
ion, The 33 patients had HCV genotype 1b and were classified into thre
e groups based on serum aminotransferase levels during and after thera
py with alpha interferon; longterm responders (n = 9), short-term resp
onders (n = 11), and nonresponders (n = 13), Changes in the genetic he
terogeneity of the hypervariable region 1 were determined by using non
isotopic polymerase chain reaction-single strand conformation polymorp
hism (PCR-SSCP). HCV RNA levels were evaluated by reverse transcriptas
e PCR and branched DNA probe assays, Changes in sequences were determi
ned by cloning and sequencing analysis, Before therapy, the long-term
responders had significantly lower degrees of heterogeneity and lower
viral levels than nonresponders. There were no significant differences
between short-term and nonresponders, With interferon therapy, viral
levels and degree of heterogeneity decreased to a greater extent among
longterm and short-term responders than among nonresponders, Sequenci
ng analysis showed that the three groups had similar clone numbers ini
tially, but longterm responders had rather homogeneous viral populatio
ns, whereas short-term and nonresponders had heterogeneous populations
, but that there were no nucleotide sequences or amino acid alignments
that were specific for any group before, during, and 6 months after t
herapy. Approximately half of short-term and nonresponders received a
second course of interferon 7 to 10 months after the initial therapy;
all showed an identical response to the second course of therapy regar
dless of interim changes in the heterogeneity of hypervariable region
1, These findings suggest that (1) patients who were nonresponders or
short-term responders had mixed viral populations that had differing s
ensitivities to interferon, (2) the changes in the hypervariable regio
n 1 (HVR 1) did not affect responsiveness to interferon, and (3) the l
ower heterogeneity in the HVR 1 was associated with a long-term respon
se to interferon only when the viral levels were low.